InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Borthwick Kathleen. Director active across 1 company, notably Passage BIO, Inc.. Aggregated, 4 filings have been logged. Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Kathleen Borthwick appears in 4 filings in total, all relating to Passage BIO, Inc., where she serves as CFO. In the 4 sampled filings, the period runs from 2024-01-03 to 2026-01-12, and the most common transaction nature is Levée d'options.